10-QPharmacy Retail

CVS HEALTH CORPORATION

CVS · Period ending 2026-03-31 · Filed 2026-05-06

Valuation

Pharmacy Retail
Live · Yahoo Finance

Price

$106.89

52-Week Range

$58.50$106.89 now$110.68

Decision Context

Altman Z-Score indicates financial distress risk. Review debt levels and cash runway before any position sizing decision.

Based on filing period ending Mar 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

CVS vs

Macro Context

SWOT Analysis — CVS

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.

Strengths

  • Operating Cash Flow: $10.6B (+16.8% YoY) — Operating cash flow grew 17% — the business generated more cash from day-to-day operations.

  • Revenue: $402.1B (+7.8% YoY) — Revenue grew 8% — the company sold more goods or services than the prior year.

Weaknesses

  • EPS (Diluted): $1.39 (-62.0% YoY) — Earnings per share fell 62%.

  • Net Income: $1.8B (-61.7% YoY) — Profit fell 62% but remained positive.

  • Gross Profit: $28.5B (-1.1% YoY) — Gross profit declined 1% — costs are growing faster than revenue.

Opportunities

No clear opportunities identified at this time.

Threats

  • Current ratio of 0.84x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

  • Net income dropped 62% year-over-year — a significant compression in profitability.

Financial Charts

Revenue vs Net Income

Gross Profit vs Operating Income

Margin Trend

Year-over-Year Changes

EPS (Diluted)

$1.39

was $3.66

−62.0%

Earnings per share fell 62%.

Net Income

$1.8B

was $4.6B

−61.7%

Profit fell 62% but remained positive.

Operating Cash Flow

$10.6B

was $9.1B

+16.8%

Operating cash flow grew 17% — the business generated more cash from day-to-day operations.

Revenue

$402.1B

was $372.8B

+7.8%

Revenue grew 8% — the company sold more goods or services than the prior year.

Gross Profit

$28.5B

was $28.9B

−1.1%

Gross profit declined 1% — costs are growing faster than revenue.

Risk Flags

1 high · 1 medium · 0 low
  • High

    Current ratio of 0.84x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

  • Medium

    Net income dropped 62% year-over-year — a significant compression in profitability.

Price History

Technical Signals

Daily closes · 1-year data

Latest News

via Finnhub

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade CVS

Links open broker research pages. Not an endorsement or recommendation.

Research CVS HEALTH CORPORATION

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.